Literature DB >> 28029641

Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients.

Sorel Goland1, Jean Marc Weinstein2, Adi Zalik2, Rafael Kuperstein2, Liaz Zilberman2, Sara Shimoni2, Michael Arad2, Tuvia Ben Gal2, Jacob George2.   

Abstract

BACKGROUND: Recent studies suggest that angiogenic imbalance during pregnancy may lead to acute peripartum cardiomyopathy (PPCM). We propose that angiogenic imbalance and residual cardiac dysfunction may exist even after recovery from PPCM. METHODS AND
RESULTS: Twenty-nine women at least 12 months after presentation with PPCM, who exhibited recovery of left ventricular (LV) ejection fraction (≥50%), were included in the study (mean age 35±6 years, LV ejection fraction 61.0±3.9%). The number of circulating endothelial progenitor cells (EPCs) and plasma levels of proangiogenic vascular endothelial growth factor and of soluble vascular endothelial growth factor receptor Flt1 (sFlt1) were measured. All patients underwent comprehensive cardiac function assessment, including tissue Doppler imaging and 2-dimensional (2D) strain echocardiography. All measurements were compared with healthy controls. Patients with a history of PPCM have significantly higher sFlt1 concentrations (median [25th-75th percentile]; 149.57, [63.14-177.89] versus 20.29, [15.00-53.89] pg/mL, P<0.001) and significantly decreased vascular endothelial growth factor/sFlt1 ratio (P=0.012) compared with controls, with a trend toward lower concentration of circulating CD34+/KDR+ levels. In addition, patients with PPCM had lower early velocities E' septal (9.9±2.1 versus 11.0±1.5 cm/s, P=0.02), with a significantly lower systolic velocity S' septal (7.6±1.2 versus 8.5±1.2 cm/s, P=0.003) by tissue Doppler imaging. Significantly lower LV global longitudinal (-19.1±3.3 versus -22.7±2.2%, P<0.001) and apical circumferential 2D strain (-16.6±4.9 versus -21.2±7.9, P=0.02) were present in patients with PPCM compared with controls.
CONCLUSIONS: Higher concentration of sFlt1 with concomitant decreased circulating endothelial progenitor cell levels along with inappropriate attenuated vascular endothelial growth factor levels may imply an angiogenic imbalance that exists even after recovery and may thus predispose to PPCM. In addition, tissue Doppler imaging and 2D strain were able to identify residual myocardial injury in post-PPCM women with apparent recovery of LV systolic function. Both angiogenic imbalance and residual myocardial injury may play an important role in the recurrence of LV dysfunction during subsequent pregnancies.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathycirculating endothelial progenitor cells; echocardiography; pregnancyvascular endothelial growth factorsVEGF receptor, FLT

Mesh:

Substances:

Year:  2016        PMID: 28029641     DOI: 10.1161/CIRCHEARTFAILURE.116.003349

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  8 in total

1.  Impact of Preeclampsia on Clinical and Functional Outcomes in Women With Peripartum Cardiomyopathy.

Authors:  Kathryn J Lindley; Shayna N Conner; Alison G Cahill; Eric Novak; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2017-06       Impact factor: 8.790

Review 2.  Pathophysiology and risk factors of peripartum cardiomyopathy.

Authors:  Martijn F Hoes; Zoltan Arany; Johann Bauersachs; Denise Hilfiker-Kleiner; Mark C Petrie; Karen Sliwa; Peter van der Meer
Journal:  Nat Rev Cardiol       Date:  2022-01-11       Impact factor: 49.421

3.  Increased arterial stiffness and reduced left ventricular long-axis function in patients recovered from peripartum cardiomyopathy.

Authors:  Magnus C Johansson; Anders Barasa; Carmen Basic; Gunnar Nyberg; Maria Schaufelberger
Journal:  Clin Physiol Funct Imaging       Date:  2020-11-06       Impact factor: 2.273

Review 4.  Advancement in Current Therapeutic Modalities in Postpartum Cardiomyopathy.

Authors:  Kamlesh Chaudhari; Mahak Choudhary; Kushagra Chaudhari; Neeta Verma; Sunil Kumar; Sparsh Madaan; Dhruv Talwar
Journal:  Cureus       Date:  2022-03-03

5.  ZFP36L2 suppresses mTORc1 through a P53-dependent pathway to prevent peripartum cardiomyopathy in mice.

Authors:  Hidemichi Kouzu; Yuki Tatekoshi; Hsiang-Chun Chang; Jason S Shapiro; Warren A McGee; Adam De Jesus; Issam Ben-Sahra; Zoltan Arany; Jonathan Leor; Chunlei Chen; Perry J Blackshear; Hossein Ardehali
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

Review 6.  Cardiotoxicity with vascular endothelial growth factor inhibitor therapy.

Authors:  Rhian M Touyz; Joerg Herrmann
Journal:  NPJ Precis Oncol       Date:  2018-05-08

7.  Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.

Authors:  Anne S Ersbøll; Annemie S Bojer; Maria G Hauge; Marianne Johansen; Peter Damm; Finn Gustafsson; Niels G Vejlstrup
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

8.  A Case-Control Study of Peripartum Cardiomyopathy Using the Rochester Epidemiology Project.

Authors:  Erika J Douglass; Leslie T Cooper; A Carolina Morales-Lara; Demilade A Adedinsewo; Todd D Rozen; Lori A Blauwet; Delisa Fairweather
Journal:  J Card Fail       Date:  2021-01-01       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.